0001140361-17-021016.txt : 20170516 0001140361-17-021016.hdr.sgml : 20170516 20170516165743 ACCESSION NUMBER: 0001140361-17-021016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170512 FILED AS OF DATE: 20170516 DATE AS OF CHANGE: 20170516 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytomX Therapeutics, Inc. CENTRAL INDEX KEY: 0001501989 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273521219 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.515.3185 MAIL ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goeltz II Robert C. CENTRAL INDEX KEY: 0001653881 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37587 FILM NUMBER: 17849353 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc1.xml FORM 4 X0306 4 2017-05-12 1 0001501989 CytomX Therapeutics, Inc. CTMX 0001653881 Goeltz II Robert C. 151 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Common Stock 2017-05-12 4 M 0 9980 4.4728 A 22769 D Common Stock 2017-05-12 4 M 0 9987 6.6147 A 32756 D Stock Option (Right to Buy) 4.4728 2017-05-12 4 M 0 9980 0.00 D 2025-05-06 Common Stock 9980 204678 D Stock Option (Right to Buy) 6.6147 2017-05-12 4 M 0 9987 0.00 D 2025-08-25 Common Stock 9987 85891 D This option vests 25% on May 4, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on May 4, 2019. This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month starting in September 2015. /s/ Cynthia J. Ladd, as Attorney-in-Fact for Robert C. Goeltz II 2017-05-16